<DOC>
	<DOCNO>NCT01710982</DOCNO>
	<brief_summary>A study evaluate safety TZP-101 comparison placebo administer post-operatively patient undergone partial bowel resection .</brief_summary>
	<brief_title>A Study Evaluate Safety TZP-101 ( IV Ulimorelin ) Administered Post-Operatively Patients Who Have Undergone Partial Bowel Resection</brief_title>
	<detailed_description />
	<criteria>Patient 18 80 year age , inclusive . Patient schedule undergo open bowel resection . Female patient must postmenopausal ( least 1 year ) , surgically sterile , practice true sexual abstinence , OR must use adequate contraception ( opinion investigator ) duration study , include followup period ( e.g . contraceptive implant , injectables , oral contraceptive , intrauterine device [ IUD ] , and/or barrier method ( condom occlusive cap ) spermicidal foam/gel/film/cream/suppository ) . Hormonal IUD method contraception must establish period 3 month prior dose , change , alternative method use direct investigator throughout duration study . Females childbearing potential must negative pregnancy test screen admission After surgery prior administration first dose study drug , follow eligibility criterion must assess : Patient underwent open bowel resection . Patient give write informed consent Patient weigh 200kg ( 441 pound ) . Patient classify American Society Anesthesiologists ( ASA ) Class 4 , 5 , 6 Patient complete bowel obstruction . Patient schedule receive low rectal anal anastomosis ( e.g . proctectomy ileoanal anastomosis ) ( low rectal define anterior peritoneal reflection typically 910cm anal verge ) . Patient schedule laparoscopic laparoscopic handassisted procedure . Patient 's surgical procedure consider emergency procedure . Patient significant impairment liver renal function ( alanine aminotransferase ( ALT ) / aspartate aminotransferase ( AST ) 2.5 time upper limit normal ; creatinine clearance &lt; 30mL/minute ( min ) , estimate use serum creatinine formula [ ( 140 age year ) × weight kg ] / [ ( 72 × serum creatinine mg/dl ) × 0.85 female patient ] . Patient anticipate require prolonged postoperative ventilation . Patient psychiatric disorder cognitive impairment , opinion Investigator , would interfere participation study . Patient participate investigational drug study 30 day prior study initiation . Patient positive laboratory test result control substance ( prescribe medical professional and/or account concomitant medication ) screen . Patient know Hepatitis B Hepatitis C infection currently associate clinically significant symptom abnormal liver function . Patient recent , adult history clinically significant hypersensitivity reaction ( ) drug , opinion Investigator . Patient pregnant ( confirmed pregnancy test ) breastfeeding . Patient known history drug alcohol abuse within previous year . After surgery prior administration first dose study drug , follow eligibility criterion must assess : Patient receive low rectal anal anastomosis ( e.g . proctectomy ileoanal anastomosis ) ( low rectal define anterior peritoneal reflection typically 910cm anal verge ) . Patient underwent laparoscopic procedure ( include handassisted laparoscopic procedure ) . Patient classify American Society Anesthesiologists ( ASA ) Class 4 , 5 , 6 . Patients receive ulimorelin previously</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>